PMID- 14735293 OWN - NLM STAT- MEDLINE DCOM- 20041122 LR - 20181113 IS - 0033-3158 (Print) IS - 0033-3158 (Linking) VI - 173 IP - 3-4 DP - 2004 May TI - Effect of 5-HT depletion by MDMA on hyperthermia and Arc mRNA induction in rat brain. PG - 346-52 AB - RATIONALE: 3,4-Methylenedioxymethamphetamine (MDMA) administration to rats produces an acute hyperthermic response and induces localised neuronal activation, which can be visualised via expression of immediate-early genes. The pharmacological and anatomical basis of these effects are unclear. At high doses, MDMA also causes selective neurotoxicity at serotonergic nerve terminals. OBJECTIVE: We investigated the effect of 5-hydroxytryptamine (5-HT) depletion on the acute hyperthermic response to MDMA and the pattern of neuronal excitation indicated by Arc (activity-regulated cytoskeleton associated gene) in naive rats and following administration of MDMA at a neurotoxic dose. METHODS: Expression of Arc mRNA was investigated by in situ hybridisation histochemistry using 35S-labelled oligonucleotide probe. RESULTS: MDMA induced a significant hyperthermia together with increased Arc mRNA expression in cortical regions, caudate-putamen and CA1 hippocampus but not hypothalamus. At 21 days after a neurotoxic dose of MDMA, brain 5-HT and 5-HIAA levels were significantly reduced by 21-32%. In these animals, both the hyperthermic response and the pattern and extent of Arc mRNA expression induced by a subsequent dose of MDMA were unaltered. However, basal Arc expression was significantly increased in cortical regions and CA1 hippocampus. CONCLUSION: We conclude that the acute hyperthermic response induced by MDMA is not attenuated by moderate depletion of 5-HT, further questioning mediation via a serotonergic mechanism. Arc mRNA induction by MDMA exhibits highly localised expression, which is not altered following 5-HT depletion. However, following a neurotoxic dose of MDMA, basal expression of Arc is increased, particularly in cortex and CA1, suggesting that mechanisms underlying synaptic plasticity might also be modified. FAU - Beveridge, Thomas J R AU - Beveridge TJ AD - School of Pharmacy, De Montfort University, Leicester, LE1 9BH, UK. FAU - Mechan, Annis O AU - Mechan AO FAU - Sprakes, Marie AU - Sprakes M FAU - Pei, Qi AU - Pei Q FAU - Zetterstrom, Tyra S C AU - Zetterstrom TS FAU - Green, A Richard AU - Green AR FAU - Elliott, J Martin AU - Elliott JM LA - eng PT - Journal Article DEP - 20040120 PL - Germany TA - Psychopharmacology (Berl) JT - Psychopharmacology JID - 7608025 RN - 0 (Cytoskeletal Proteins) RN - 0 (Immediate-Early Proteins) RN - 0 (Nerve Tissue Proteins) RN - 0 (RNA, Messenger) RN - 0 (Serotonin Antagonists) RN - 0 (activity regulated cytoskeletal-associated protein) RN - 333DO1RDJY (Serotonin) RN - KE1SEN21RM (N-Methyl-3,4-methylenedioxyamphetamine) SB - IM MH - Animals MH - Brain/*metabolism MH - Cytoskeletal Proteins MH - Fever/chemically induced/*metabolism MH - Immediate-Early Proteins/*biosynthesis/genetics MH - In Situ Hybridization MH - Male MH - N-Methyl-3,4-methylenedioxyamphetamine/administration & dosage/*toxicity MH - Nerve Tissue Proteins/*biosynthesis/genetics MH - RNA, Messenger/*biosynthesis MH - Rats MH - Serotonin/*metabolism MH - Serotonin Antagonists/administration & dosage/*toxicity EDAT- 2004/01/22 05:00 MHDA- 2004/12/16 09:00 CRDT- 2004/01/22 05:00 PHST- 2003/08/02 00:00 [received] PHST- 2003/11/27 00:00 [accepted] PHST- 2004/01/22 05:00 [pubmed] PHST- 2004/12/16 09:00 [medline] PHST- 2004/01/22 05:00 [entrez] AID - 10.1007/s00213-003-1753-y [doi] PST - ppublish SO - Psychopharmacology (Berl). 2004 May;173(3-4):346-52. doi: 10.1007/s00213-003-1753-y. Epub 2004 Jan 20.